Nuwacell Biotechnologies Co., Ltd. was founded by Dr. Junying Yu, a world-famous scientist and one of the inventors of human induced pluripotent stem cells (hiPSC). Nuwacell is a high-tech enterprise focusing on hiPSC research and clinical transformation, and is committed to becoming the leading brand of domestic iPSC technology industrialization.
Since its establishment, Nuwacell has been committed to creating products and services for the entire industry chain of stem cells, and has worked closely with universities, pharmaceutical companies, and hospitals to carry out multi-directional applications. In the upstream of the industry, we have established research-grade and clinical-grade hiPSC cell banks, and actively explores the cutting-edge technology research of stem cells. In the middle reaches of the industry, we induce the differentiation of hiPSC into a variety of functional cells to provide high-quality products for medical and drug research. In the downstream of the industry, we have committed to the development of stem cell drugs, providing new weapons for a variety of refractory diseases.
Nuwacell takes "making the R & D and production of cell drugs derived from pluripotent stem cells in China reach the same level as those in developed countries" as its own responsibility. We have currently built a general-purpose hiPSC cell bank, a number of hiPSC-derived functional cell drug research and development platforms, and solidly and steadily promote the application of cell drugs according to the requirements of the National Drug Administration, providing new and more effective treatment for neurodegenerative diseases, autoimmune diseases, cancer, etc.
Nuwacell actively promotes and participates in the formulation of national stem cell standards. We also have jointly undertaken with the Institute of Zoology, Chinese Academy of Sciences, China Jiliang University and other units to undertake the National Key R&D Program of the Ministry of Science and Technology "Standardization of Stem Cell Preparations and Applications", and establish cell storage in accordance with international standards. In addition, we also cooperates with a number of domestic universities, scientific research institutes, and hospitals in basic and clinical research to jointly promote basic scientific research and clinical transformation in the field of domestic stem cells.
Looking to the future, Nuwacell will rely on the core technology platform of independent intellectual property rights, adhering to the enterprise concept of integrity, rigor, innovation and service, leading and promoting the process of China's stem cell industry, and building Nuwacell into an international first-class leading enterprise in biotechnology and biomedicine.
